Bank of New York Mellon’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.87M | Buy |
171,014
+667
| +0.4% | +$14.5K | ﹤0.01% | 2455 |
|
|
2026
Q1 | $2.96M | Buy |
170,347
+437
| +0.3% | +$8.27K | ﹤0.01% | 2605 |
|
|
2025
Q4 | $3.2M | Buy |
169,910
+15,139
| +10% | +$254K | ﹤0.01% | 2583 |
|
|
2025
Q3 | $2.25M | Buy |
154,771
+3,672
| +2% | +$52.3K | ﹤0.01% | 2737 |
|
|
2025
Q2 | $2.95M | Buy |
151,099
+9,868
| +7% | +$175K | ﹤0.01% | 2556 |
|
|
2025
Q1 | $2.51M | Sell |
141,231
-4,039
| -3% | -$87K | ﹤0.01% | 2575 |
|
|
2024
Q4 | $3.11M | Buy |
145,270
+5,502
| +4% | +$134K | ﹤0.01% | 2538 |
|
|
2024
Q3 | $4.36M | Sell |
139,768
-54,226
| -28% | -$1.35M | ﹤0.01% | 2365 |
|
|
2024
Q2 | $3.01M | Buy |
193,994
+12,404
| +7% | +$150K | ﹤0.01% | 2577 |
|
|
2024
Q1 | $1.92M | Sell |
181,590
-12,870
| -7% | -$129K | ﹤0.01% | 2780 |
|
|
2023
Q4 | $2.33M | Buy |
194,460
+9,452
| +5% | +$77.4K | ﹤0.01% | 2749 |
|
|
2023
Q3 | $1.3M | Buy |
185,008
+1,045
| +0.6% | +$9.65K | ﹤0.01% | 3026 |
|
|
2023
Q2 | $1.56M | Buy |
183,963
+12,135
| +7% | +$101K | ﹤0.01% | 2966 |
|
|
2023
Q1 | $1.57M | Sell |
171,828
-2,634
| -2% | -$33.7K | ﹤0.01% | 2927 |
|
|
2022
Q4 | $1.99M | Sell |
174,462
-13,125
| -7% | -$194K | ﹤0.01% | 2855 |
|
|
2022
Q3 | $3.19M | Sell |
187,587
-28,194
| -13% | -$605K | ﹤0.01% | 2550 |
|
|
2022
Q2 | $4.64M | Sell |
215,781
-99,444
| -32% | -$2.76M | ﹤0.01% | 2352 |
|
|
2022
Q1 | $11.7M | Sell |
315,225
-11,905
| -4% | -$464K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $14.9M | Sell |
327,130
-18,926
| -5% | -$988K | ﹤0.01% | 1890 |
|
|
2021
Q3 | $21.9M | Buy |
346,056
+20,494
| +6% | +$1.56M | ﹤0.01% | 1675 |
|
|
2021
Q2 | $29.8M | Buy |
325,562
+28,279
| +10% | +$2.25M | 0.01% | 1500 |
|
|
2021
Q1 | $20.2M | Sell |
297,283
-12,682
| -4% | -$985K | ﹤0.01% | 1702 |
|
|
2020
Q4 | $22.5M | Sell |
309,965
-4,764
| -2% | -$276K | ﹤0.01% | 1571 |
|
|
2020
Q3 | $11.9M | Buy |
314,729
+3,277
| +1% | +$111K | ﹤0.01% | 1764 |
|
|
2020
Q2 | $11M | Sell |
311,452
-13,828
| -4% | -$394K | ﹤0.01% | 1776 |
|
|
2020
Q1 | $7.1M | Buy |
325,280
+62,497
| +24% | +$1.4M | ﹤0.01% | 1882 |
|
|
2019
Q4 | $5.67M | Buy |
262,783
+1,476
| +0.6% | +$33.9K | ﹤0.01% | 2272 |
|
|
2019
Q3 | $5.91M | Buy |
261,307
+51,067
| +24% | +$1.41M | ﹤0.01% | 2191 |
|
|
2019
Q2 | $7.57M | Buy |
210,240
+19,489
| +10% | +$624K | ﹤0.01% | 2121 |
|
|
2019
Q1 | $6.01M | Sell |
190,751
-19,902
| -9% | -$580K | ﹤0.01% | 2245 |
|
|
2018
Q4 | $5.29M | Buy |
210,653
+4,468
| +2% | +$115K | ﹤0.01% | 2254 |
|
|
2018
Q3 | $5.95M | Buy |
206,185
+50,383
| +32% | +$943K | ﹤0.01% | 2323 |
|
|
2018
Q2 | $1.91M | Buy |
155,802
+87,698
| +129% | +$1.01M | ﹤0.01% | 2875 |
|
|
2018
Q1 | $543K | Sell |
68,104
-4,588
| -6% | -$28.3K | ﹤0.01% | 3553 |
|
|
2017
Q4 | $534K | Buy |
+72,692
| New | +$453K | ﹤0.01% | 3594 |
|
Other funds holding CDNA
GS
GA
Bank of New York Mellon's CDNA Position: Q2 2026 in Review
Bank of New York Mellon increased its CareDx (CDNA) stake by 0.39% in Q2 2026, buying an estimated $14.5K and bringing the position to 171,014 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2455.
Bank of New York Mellon first reported a position in CDNA in Q4 2017 and has held it in 35 quarters since. The position peaked at $29.8M in Q2 2021. 77 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Bank of New York Mellon held 171,014 shares of CareDx worth $4.87M as of Q2 2026.
- Bank of New York Mellon bought 667 CareDx shares in Q2 2026, an estimated $14.5K.
- CareDx made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2455 holding.
- Bank of New York Mellon first reported a position in CareDx in Q4 2017 and has held it in 35 quarters since.
- Bank of New York Mellon's CareDx position peaked at $29.8M in Q2 2021.
- 77 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.